Exploring actigraphy as a digital phenotyping measure: A study on differentiating psychomotor agitation and retardation in depression
Acta Psychiatrica Scandinavica · 2025-03 · 151 (3) · 401-411
DOI: 10.1111/acps.13739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Psychiatrica Scandinavica, online erschienen am 19.07.2024. Verfasst von Julia Maruani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Département de Psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, Paris, France. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
Introduction
Psychomotor activity stands out as a crucial symptom in characterizing behaviors associated with depression. This study aims to explore the potential of actigraphy as a tool for digital phenotyping in characterizing symptoms of psychomotor agitation and retardation, which are clinically challenging dimensions to capture, in patients diagnosed with major depressive episode (MDE) according to DSM‐5 criteria.
Methods
We compared rest‐activity circadian rhythm biomarkers measured by the Motion Watch 8 actigraphy between 58 (78.4%) patients with MDE and psychomotor retardation (PMR), and 16 (21.6%) patients with MDE and psychomotor agitation (PMA), according to DSM‐5 criteria.
Results
Actigraphy allowed to objectively report PMA through heightened activity over a 24‐h period, while PMR manifests as reduced activity during the most active 10 h. Lower rest‐activity rhythm (RAR) amplitude in PMR was accompanied by increased irregularities in intra‐ and inter‐day rhythms. Interestingly, actigraphy emerges as an objective tool to measure the characteristics of the active and rest periods, free from the confounding effects of sleep disturbances. Indeed, no differences in sleep disturbances were identified between patients exhibiting psychomotor agitation and those displaying PMR.
Conclusion
Digital phenotyping through actigraphy may aid in distinguishing psychomotor retardation and psychomotor agitation allowing for a more precise characterization of the depression phenotype. When integrated with clinical assessment, measurements from actigraphy could offer additional insights into activity rhythms alongside subjective assessments and hold the potential to augment existing clinical decision‐making processes in psychiatry.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département de Psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, Paris, France.
- Université Paris Cité, NeuroDiderot, Inserm, Paris, France.
- Centre ChronoS, GHU Paris - Psychiatrie & Neurosciences, Paris, France.
ORCID-Profile: Julia Maruani
Zitieren
APA
Maruani, J., Mauries, S., Zehani, F., Lejoyeux, M., & Geoffroy, P. A. (2025). Exploring actigraphy as a digital phenotyping measure: A study on differentiating psychomotor agitation and retardation in depression. Acta Psychiatrica Scandinavica, 151(3), 401-411. https://doi.org/10.1111/acps.13739
Vancouver
Maruani J, Mauries S, Zehani F, Lejoyeux M, Geoffroy PA. Exploring actigraphy as a digital phenotyping measure: A study on differentiating psychomotor agitation and retardation in depression. Acta Psychiatrica Scandinavica. 2025;151(3):401-411. doi:10.1111/acps.13739
BibTeX
@article{Maruani2025,
author = {Maruani, Julia and Mauries, Sibylle and Zehani, Feriel and Lejoyeux, Michel and Geoffroy, Pierre A},
title = {Exploring actigraphy as a digital phenotyping measure: A study on differentiating psychomotor agitation and retardation in depression},
journal = {Acta Psychiatrica Scandinavica},
year = {2025},
volume = {151},
number = {3},
pages = {401--411},
doi = {10.1111/acps.13739}
}
EUVIMED